Helping doctors ask about drug, alcohol problems
WASHINGTON — If more doctors started asking, would more drug and alcohol abusers ‘fess up so they could get help?
It’s a huge irony of health care: Go to the emergency room and you’ll be asked about a tetanus shot, even though “most of us have never seen a case of tetanus,” says Dr. Gail D’Onofrio, emergency medicine chief at Yale-New Haven Hospital.
Yet although up to half of ER visits involve illegal drugs or alcohol, typically “we don’t ask it. It makes no sense whatsoever,” says D’Onofrio, who teaches new doctors to break that chain of silence.
A new program from the National Institute on Drug Abuse aims to help health workers past the stigma and ensure that more patients are asked for simple clues to addiction at every visit — not just in the ER, but anytime they see a doctor.
It’s a step-by-step computerized guide that takes patients’ answers to various behavior questions, analyzes their risk for a serious substance use problem and tells doctors what next steps to take.
A patient admits to experimenting with heroin? A few more questions about how often, when and if he felt cravings can guide how big his risk is for ongoing drug use and what intervention is needed — plus remind the doctor to administer an HIV and hepatitis test.
Someone else insists she’s a social drinker? If she’s ever had four or more drinks in a day, she may have a bigger problem.
The goal: To get substance abuse treatment for more of the 23 million Americans estimated to need it. Only about 2 million today get that help, NIDA says.
Better would be finding people early, when substance abuse is just taking hold and a doctor intervening might keep it from getting worse. A government study last year found that some simple doctor steps — brief in-office counseling or referral to a specialty center — could help slash drug use by patients coaxed to come clean.
They have plenty of opportunity. Studies suggest people with brewing drug or alcohol problems actually see the doctor more often than their sober counterparts. They have a lot of injuries, and a tougher time with problems ranging from high blood pressure to liver disease.
“There are all sorts of people who are using alcohol, drugs, who are continuing to work and do their jobs and slowly spiraling down, who are not the hard-core users,” says Dr. Brian Jack, a family medicine specialist at Boston University Medical School. “Those are people who are in the clinics every single day for all sorts of different things.”
Hence the push for better substance abuse screening. The American College of Obstetricians and Gynecologists in December urged its members to ask every patient about alcohol or drug use. Top-level trauma centers must screen trauma patients as part of their accreditation. The government adopted new insurance payment codes last year so doctors could bill for screening time.
The new federal program, called NIDAMED, aims to break another barrier: How doctors not trained in addiction medicine can tell the difference between experimenting and abuse, and what they should do for a patient with a problem. Already, New York City officials have told the government they’re planning to incorporate NIDAMED into the health department’s electronic medical records, enabling more than 1,000 providers in underserved parts of the city to use it.
Don’t patients just lie? Sure, some do. “Help your doctor read between the lines,” says patient information accompanying NIDAMED.
There are consequences. Lie about what’s in your system and you might be prescribed a legal drug that could trigger a deadly interaction. Lie if you’re pregnant and you can hurt your baby. The key, say doctors who routinely screen, is earning patients’ trust and explaining they’re not being judgmental: Substance use is a medical problem.
“We’re not the police,” says D’Onofrio. Medical information is confidential.
“Get to know them as a person and treat them as a person, and care, frankly,” adds Jack.
Dana Moulton of Boston recalls long ago being hospitalized with hepatitis and concealing that he was trying to kick a nearly 20-year heroin addiction. But one doctor sat by his bedside, talking about a mutual love of books and eventually coaxing Moulton to reveal his struggles in methadone treatment. Moulton credits that doctor’s help with his success in going drug-free a decade ago.
“It was the first time someone did not stigmatize me, showed me genuine concern about my health issues despite the fact that I was a substance abuser,” recalled Moulton, now 58 and with Massachusetts’ substance-abuse office. “He dealt with me as a human being.”
EDITOR’S NOTE — Lauran Neergaard covers health and medical issues for The Associated Press in Washington.
Related News
Senator says Medicare payment switch will push doctors to more expensive Genentech eye drugOctober 13th, 2009 Kohl probes Medicare pay switch on Genentech drugsWASHINGTON — A Democratic senator says a shift in Medicare policy would encourage doctors to use an eye drug that costs thousands of dollars, over a similar treatment that costs just $50. The change would benefit drugmaker Genentech, which makes both drugs, but insists the more expensive one is better for patients.
Catalyst says it sees evidence its drug vigabatrin is effective despite failures; study surgesOctober 1st, 2009 Catalyst plans more tests of anti-addiction drugNEW YORK — Catalyst Pharmaceutical Partners Inc. says it will continue developing an anti-addiction drug that has failed in two clinical trials, as it believes the treatment is safe and effective.
Organizations to kickoff campaign targeting drug, alcohol abuse by teens in military familiesSeptember 30th, 2009 Campaign targets military teens' alcohol, drug useWASHINGTON — Concerned about drug and alcohol use among teens in military families, three organizations are undertaking an online educational campaign on Wednesday to encourage parents and children to talk about substance abuse. The Partnership for a Drug-Free America, along with the National Military Family Association and the National Association of School Nurses, are providing guidance and scripts online to the parents of military kids about good ways to bring up what the teens are going through.
British doctors call for blanket ban on alcohol advertising to control country's drinkingSeptember 8th, 2009 British doctors call for ban on all alcohol adsLONDON — British doctors called for a ban on alcohol advertisements Tuesday, saying the move was necessary to challenge Britain's dangerous drinking culture. The British Medical Association argued in a report that a rapid increase in alcohol consumption among young Britons in recent years was being underpinned by "clever alcohol advertising" and that a prohibition on alcohol-related publicity was needed to help turn the situation around.
HEALTHBEAT: Improving health care quality at below-average prices? Some communities are tryingSeptember 7th, 2009 Better care, pay less: Some communities find a wayWASHINGTON — If you pay the mechanic $1,000 to fix your transmission and it breaks again next week, the garage should find and fix the problem for free. So if you get an infection following open-heart surgery because the doctor forgot an antibiotic, why are you charged extra to clear up the wound?
At Geisinger Health System in Pennsylvania, pay a flat fee for bypass surgery and you'll get essentially a 90-day warranty on your heart fix.
Study shows experimental drug cuts stroke risk in patients with irregular heartbeatsAugust 30th, 2009 Study shows experimental drug cuts stroke riskBARCELONA, Spain — An experimental drug reduces the stroke risk in patients with irregular heartbeats by nearly four times, compared with the popular drug warfarin — but possibly at a cost, according to new research released Sunday. Patients taking the new drug dabigatran etexilate, made by German pharmaceutical Boehringer Ingelheim, also were slightly more likely to have heart attacks or stomach pain, according to the research presented at the European Society of Cardiology meeting in Barcelona.
New anti-clotting drug reduces heart patients' chances of dyingAugust 30th, 2009 New drug reduces risks for heart patientsBARCELONA, Spain — A new drug to prevent blood clots in heart patients reduced their chances of dying by more than 20 percent compared to the standard treatment, new research says. Researchers followed 18,624 patients worldwide from 2006 to 2008.
AstraZeneca says Brilinta anti-clotting drug reduces chance of dying better than PlavixAugust 30th, 2009 New AstraZeneca drug reduces heart patients' risksBARCELONA, Spain — A new drug to prevent blood clots in heart patients reduced their chances of dying by more than 20 percent compared with the standard treatment, new research says. Researchers followed 18,624 patients worldwide from 2006 to 2008.
CBO: Some seniors could see drug costs rise under House bill but on average would spend lessAugust 28th, 2009 CBO: House bill could raise drug costs for someWASHINGTON — Some seniors could end up paying 20 percent more for their Medicare prescription drug plans under health care legislation in the House. But overall prescription drug spending would decrease for seniors on average under the bill, the Congressional Budget Office said Friday in a new report.
Federal appeals court revives whistle-blower suit alleging J&J illegally marketed anemia drugAugust 13th, 2009 Federal court OKs suit alleging illegal J&J salesBOSTON — A federal appeals court has revived a multibillion-dollar Medicare fraud case brought by whistle-blowers alleging Johnson & Johnson paid doctors kickbacks to wrongly prescribe an expensive drug. Two former salespeople for the health care giant allege J&J illegally marketed its blockbuster anemia drug Procrit.
Supreme Court won't decide whether law making doctor's prescription pad private constitutionalJune 29th, 2009 Court won't decide privacy of prescription padsWASHINGTON — The Supreme Court won't stop the state of New Hampshire from making doctors' prescription-writing habits confidential over the objection of companies who analyze and sell that information. The high court on Monday refused to hear an appeal from IMS Health Inc.
Experimental drug shows promise in treating head, neck cancersApril 29th, 2009 WASHINGTON - An anti-cancer compound studied for treating blood cancers may also help in treating cancers of the head and neck, say researchers at Albert Einstein College of Medicine of Yeshiva University. The study involved a new class of chemotherapy agents known as histone deacetylase (HDAC) inhibitors, which affect the availability of genes that are transcribed and translated into proteins.
Intel and GE team up on telemedicineApril 2nd, 2009 NEW YORK - Going to the doctor could become a thing of the past for many people if the telemedicine plans by Intel and General Electric (GE) come to fruition. The two giant US companies announced Thursday that they are teaming up to produce a line of medical devices, including one that would allow doctors to remotely monitor patients' health without them needing to visit the doctor's office.
Scientists identify genes that determine right warfarin doseMarch 21st, 2009 WASHINGTON - Researchers at Uppsala University, together with colleagues at Karolinska Institute and Sanger Institute, have identified three genes that would help determine the optimal dose of blood-thinning drug warfarin. The team led by Mia Wadelius have come across three genes VKORC1, CYP2C9, and CYP4F2 that would help determine adequate warfarin dosage.
PM doing 'very well', to return home 'in a few days'January 29th, 2009 NEW DELHI - Prime Minister Manmohan Singh is 'convalescing very well' following his heart surgery and doctors feel that he can return home 'in a few days', a senior official said Friday. Manmohan Singh's dietary intake has increased and doctors have told him to 'progressively step up physical activity' over the next four weeks, the prime minister's media adviser Deepak Sandhu told IANS.